BACKGROUND: Human papillomavirus (HPV) causes external genital lesions (EGLs) in men, including condyloma and penile intraepithelial neoplasia (PeIN). We sought to determine the incidence of pathologically confirmed EGLs, by lesion type, among men in different age groups and to evaluate the HPV types that were associated with EGL development. METHODS: HPV Infection in Men (HIM) study participants who contributed ≥2 visits from 2009-2013 were included in the biopsy cohort. Genotyping by an HPV line-probe assay was performed on all pathologically confirmed EGLs. Age-specific analyses were conducted for incident EGLs, with Kaplan-Meier estimation of cumulative incidence. RESULTS: This biopsy cohort included 2754 men (median follow-up duration, 12.4 months [interquartile range, 6.9-19.2 months]). EGLs (n = 377) were pathologically confirmed in 228 men, 198 of whom had incident EGLs. The cumulative incidence of any EGL was highest among men <45 years old and, for condyloma, decreased significantly over time with age. The genotype-specific incidence of EGL varied by pathological diagnoses, with high- and low-risk genotypes found in 15.6% and 73.2% of EGLs, respectively. Condyloma primarily contained HPV 6 or 11. While PeIN lesions primarily contained HPV 16, 1 PeIN III lesion was positive for HPV 6 only. CONCLUSION: Low- and high-risk HPV genotypes contribute to the EGL burden. Men remain susceptible to HPV-related EGLs throughout the life span, making it necessary to ensure the longevity of immune protection against the most common causative HPV genotypes.
BACKGROUND:Human papillomavirus (HPV) causes external genital lesions (EGLs) in men, including condyloma and penile intraepithelial neoplasia (PeIN). We sought to determine the incidence of pathologically confirmed EGLs, by lesion type, among men in different age groups and to evaluate the HPV types that were associated with EGL development. METHODS:HPV Infection in Men (HIM) study participants who contributed ≥2 visits from 2009-2013 were included in the biopsy cohort. Genotyping by an HPV line-probe assay was performed on all pathologically confirmed EGLs. Age-specific analyses were conducted for incident EGLs, with Kaplan-Meier estimation of cumulative incidence. RESULTS: This biopsy cohort included 2754 men (median follow-up duration, 12.4 months [interquartile range, 6.9-19.2 months]). EGLs (n = 377) were pathologically confirmed in 228 men, 198 of whom had incident EGLs. The cumulative incidence of any EGL was highest among men <45 years old and, for condyloma, decreased significantly over time with age. The genotype-specific incidence of EGL varied by pathological diagnoses, with high- and low-risk genotypes found in 15.6% and 73.2% of EGLs, respectively. Condyloma primarily contained HPV 6 or 11. While PeIN lesions primarily contained HPV 16, 1 PeIN III lesion was positive for HPV 6 only. CONCLUSION: Low- and high-risk HPV genotypes contribute to the EGL burden. Men remain susceptible to HPV-related EGLs throughout the life span, making it necessary to ensure the longevity of immune protection against the most common causative HPV genotypes.
Authors: Siolian L R Ball; David M Winder; Katie Vaughan; Nashat Hanna; Jonathan Levy; Jane C Sterling; Margaret A Stanley; Peter K C Goon Journal: J Med Virol Date: 2011-08 Impact factor: 2.327
Authors: Birgitte Baldur-Felskov; Charlotte Gerd Hannibal; Christian Munk; Susanne K Kjaer Journal: Cancer Causes Control Date: 2011-11-19 Impact factor: 2.506
Authors: Núria Guimerà; Belén Lloveras; Jan Lindeman; Laia Alemany; Miekel van de Sandt; Maria Alejo; Gustavo Hernandez-Suarez; Ignacio G Bravo; Anco Molijn; David Jenkins; Antonio Cubilla; Nubia Muñoz; Silvia de Sanjose; Francesc Xavier Bosch; Wim Quint Journal: Am J Surg Pathol Date: 2013-09 Impact factor: 6.394
Authors: Alyssa M Cornall; Jennifer M Roberts; Suzanne M Garland; Richard J Hillman; Andrew E Grulich; Sepehr N Tabrizi Journal: Int J Cancer Date: 2013-05-29 Impact factor: 7.396
Authors: Paul K S Chan; Alfred C S Luk; Tommy N M Luk; Kwong-Fai Lee; Jo L K Cheung; King-Man Ho; Kuen-Kong Lo Journal: J Clin Virol Date: 2008-12-18 Impact factor: 3.168
Authors: Matthew G Hawkins; David M Winder; Siolian L R Ball; Katie Vaughan; Christopher Sonnex; Margaret A Stanley; Jane C Sterling; Peter K C Goon Journal: Virol J Date: 2013-05-01 Impact factor: 4.099
Authors: Brenda Y Hernandez; Marc T Goodman; Elizabeth R Unger; Martin Steinau; Amy Powers; Charles F Lynch; Wendy Cozen; Maria Sibug Saber; Edward S Peters; Edward J Wilkinson; Glenn Copeland; Claudia Hopenhayn; Youjie Huang; Meg Watson; Sean F Altekruse; Christopher Lyu; Mona Saraiya Journal: Front Oncol Date: 2014-02-05 Impact factor: 5.738
Authors: Staci L Sudenga; Donna J Ingles; Christine M Pierce Campbell; Hui-Yi Lin; William J Fulp; Jane L Messina; Mark H Stoler; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: Eur Urol Date: 2015-06-06 Impact factor: 20.096
Authors: Staci L Sudenga; B Nelson Torres; Roberto Silva; Luisa L Villa; Eduardo Lazcano-Ponce; Martha Abrahamsen; Maria Luiza Baggio; Jorge Salmeron; Manuel Quiterio; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-04-26 Impact factor: 4.254
Authors: Staci L Sudenga; B Nelson Torres; William J Fulp; Roberto Silva; Luisa L Villa; Eduardo Lazcano-Ponce; Donna J Ingles; Mark Stoler; Jane L Messina; Martha Abrahamsen; Maria Luiza Baggio; Jorge Salmeron; Manuel Quiterio; Anna R Giuliano Journal: Int J Cancer Date: 2016-10-20 Impact factor: 7.396
Authors: Ema Flores-Díaz; Karen A Sereday; Silvaneide Ferreira; Bradley Sirak; João Simão Sobrinho; Maria Luiza Baggio; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero Journal: J Infect Dis Date: 2017-02-15 Impact factor: 5.226
Authors: Christine M Pierce Campbell; Tarik Gheit; Massimo Tommasino; Hui-Yi Lin; B Nelson Torres; Jane L Messina; Mark H Stoler; Dana E Rollison; Bradley A Sirak; Martha Abrahamsen; Roberto J Carvalho da Silva; Laura Sichero; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: Virology Date: 2016-08-10 Impact factor: 3.616
Authors: Anna R Giuliano; Raphael Viscidi; B Nelson Torres; Donna J Ingles; Staci L Sudenga; Luisa L Villa; Maria Luiza Baggio; Martha Abrahamsen; Manuel Quiterio; Jorge Salmeron; Eduardo Lazcano-Ponce Journal: Papillomavirus Res Date: 2015-12-01
Authors: Shams Rahman; Dana E Rollison; Christine M Pierce Campbell; Tim Waterboer; Angelika Michel; Michael Pawlita; Luisa L Villa; Eduardo Lazcano Ponce; Wei Wang; Amy R Borenstein; Anna R Giuliano Journal: PLoS One Date: 2016-11-28 Impact factor: 3.240
Authors: Staci L Sudenga; Sarah C Lotspeich; Alan G Nyitray; Bradley Sirak; Bryan E Shepherd; Jane Messina; Karen A Sereday; Roberto Carvalho Silva; Martha Abrahamsen; Maria Luiza Baggio; Manuel Quiterio; Eduardo Lazcano-Ponce; Luisa Villa; Anna R Giuliano Journal: Sex Transm Dis Date: 2022-01-01 Impact factor: 3.868